Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 3—September 1998
THEME ISSUE
ICEID 1998
Populations at Risk

Nosocomial Infection Update

Robert A. Weinstein
Author affiliation: Cook County Hospital & Rush Medical College, Chicago, Illinois, USA

Main Article

Table 1

Nosocomial infections, United States (2,3)

Year Admissions
(x106) Patient daysa
(x106) Length of stay (days) Nosocomial
infection (x106) Nosocomial infections (/1000 patient days)
1975 38 299 7.9 2.1 7.2
1995 36 190 5.3 1.9 9.8

aPatient days = total inpatient days

Main Article

References
  1. Haley  RW, Culver  DH, White  J, Morgan  WM, Amber  TG, Mann  VP, The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121:182–205.PubMedGoogle Scholar
  2. Haley  RW, Culver  DH, White  JW, Morgan  WM, Emori  TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol. 1985;121:159–67.PubMedGoogle Scholar
  3. New York Times 1998 Mar 12; Sect. A12.
  4. Centers for Disease Control and Prevention, Hospital Infections Program. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996: A report from the NNIS System. Am J Infect Control. 1996;24:380–8. DOIPubMedGoogle Scholar
  5. Slaughter  S, Hayden  MK, Nathan  C, Hu  TC, Rice  T, Van Voorhis  J, A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996;125:448–56.PubMedGoogle Scholar
  6. Bonten  MJM, Hayden  MK, Nathan  C, Van Voorhis  J, Matushek  M, Slaughter  S, Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348:1615–9. DOIPubMedGoogle Scholar
  7. Hiramatsu  K, Aritaka  N, Hanaki  H, Kawasaki  S, Hosoda  Y, Hori  S, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350:1670–3. DOIPubMedGoogle Scholar
  8. Webster  RG. Influenza: an emerging disease. Emerg Infect Dis. 1998;4. DOIPubMedGoogle Scholar
  9. Fridkin  SK, Welbel  SF, Weinstein  RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am. 1997;11:479–96. DOIPubMedGoogle Scholar
  10. Weinstein  RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;91:179–84. DOIPubMedGoogle Scholar
  11. Archibald  L, Phillips  L, Monnet  D, McGowan  JE, Tenover  F, Gaynes  R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1997;24:211–5.PubMedGoogle Scholar
  12. Scheckler  WE, Brimhall  D, Buck  AS, Farr  BM, Friedman  C, Garibaldi  RA, Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Infect Control Hosp Epidemiol. 1998;19:114–24. DOIPubMedGoogle Scholar
  13. Goldmann  DA, Weinstein  RA, Wenzel  RP, Tablan  OC, Duma  RJ, Gaynes  RP, Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234–40. DOIPubMedGoogle Scholar
  14. Tenover  FC, Arbeit  RD, Goering  RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect Control Hosp Epidemiol. 1997;18:426–39. DOIPubMedGoogle Scholar
  15. Weinstein  RA. SHEA consensus panel report: a smooth takeoff. Infect Control Hosp Epidemiol. 1998;19:91–3. DOIPubMedGoogle Scholar

Main Article

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external